CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed

Following two years of construction work, CDMO Siegfried has officially opened its new development centre

CDMO CordenPharma has acquired the finished drug product manufacturing business of Vifor Pharma Group, which

Lonza has recently announced three specific investments in the pharma sector in recent weeks. It